1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Ondansetron |
| brand | String | Zofran, Zofran ODT |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:5-HT3_antagonists|5-HT3 receptor antagonist]] • [[:Category:Antiemetics|Antiemetic]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000374-QINU`"', '"`UNIQ--vote-00000375-QINU`"', '"`UNIQ--vote-00000376-QINU`"', '"`UNIQ--vote-00000377-QINU`"' |
| starting_dose | String | 4-8 mg PO or IV every 8 hours as needed; 16 mg single dose preoperatively for PONV prevention |
| preparations | String | 4 mg, 8 mg, 24 mg tablets; 4 mg, 8 mg orally disintegrating tablets; 4 mg/5 mL oral solution; IV (2 mg/mL) |
| fda_max | String | Single doses ≤16 mg (FDA 2012 advisory withdrew the 32 mg single IV dose for QT-prolongation risk); 24-32 mg/d divided |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • IV • IM |
| onset | String | 30 minutes PO; minutes IV |
| duration | String | 4-12 hours |
| halflife | String | 3-6 hours (longer in hepatic impairment)'"`UNIQ--ref-00000378-QINU`"' |
| bioavailability | String | ~60% (oral)'"`UNIQ--ref-00000379-QINU`"' |
| pregnancy | String | |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
